Sansure Biotech announced that a portion of shares held by former shareholder Chen Wenyi, who previously held more than 5%, is subject to judicial enforcement. The Zhuzhou Intermediate People's Court in Hunan Province plans to sell a total of 5.71 million unrestricted tradable shares held by Chen through block trades or centralized bidding in batches, representing 0.99% of the company's total share capital, with the reduction period no later than December 30, 2027. After this enforcement, Chen's shareholding will decrease from 26.4274 million shares to 20.7174 million shares, and his stake will drop from 4.56% to 3.58%. This matter will not affect the stability of the company's control and will not impact daily operations.
Sansure Biotech IncFormer shareholder faces judicial enforcement selling 0.99% of shares, reducing stake and potentially pressuring stock.
